Bilateral Myelin Oligodendrocyte Glycoprotein (Mog)-Igg Associated Optic Neuritis in a Child
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)
DOI: 10.25258/ijddt.16.43s.89 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Nivedita S Nanda und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Optic Neuritis is an antibody-mediated demyelinating disease of the central nervous system (CNS). Here is a case report of an 8-year-old girl presented with sudden onset, painless, progressive diminution of vision in both eyes. On ophthalmic evaluation, findings were suggestive of optic neuritis of unknown etiology. Anti MOG IgG antibodies was found to be positive. Patient improved with Intravenous methylprednisolone therapy of three days. Hence, MOG antibody-associated optic neuritis should be considered as differential diagnosis in pediatric patients with bilateral optic disc edema and sudden vision loss.
Zitieren
APA
Nanda, N. S., Bubanale, S. C., & Bhargava, S. (2026). Bilateral Myelin Oligodendrocyte Glycoprotein (Mog)-Igg Associated Optic Neuritis in a Child. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.89
Vancouver
Nanda NS, Bubanale SC, Bhargava S. Bilateral Myelin Oligodendrocyte Glycoprotein (Mog)-Igg Associated Optic Neuritis in a Child. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.89
BibTeX
@article{Nanda2026,
author = {Nanda, Nivedita S and Bubanale, Shivanand C and Bhargava, Shubhra},
title = {Bilateral Myelin Oligodendrocyte Glycoprotein (Mog)-Igg Associated Optic Neuritis in a Child},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {43s},
doi = {10.25258/ijddt.16.43s.89}
}
EUVIMED